| Shayne Cox Gad - 2005 - 1494 стор.
...WP, Rowinsky, EK, Rosenheim, NB, Grumbine, F. C, Ettinger, D. S., Armstong, DK, Donehower, RC (1989). Taxol: a unique antineoplastic agent with significant...epithelial neoplasms. Annals of Internal Medicine, 111, 273-279. 111. Mehta, G., Singh, V. (2002). Hybrid systems through natural product leads: an approach... | |
| Marie A. Simmons - 2005 - 160 стор.
...Rowinsky, EK, Rosenshein, NB, Grumbine, FC, Ettinger, DS, Armstrong, DK, and Donehower, RC (1989). Taxol: A unique antineoplastic agent with significant...activity in advanced ovarian epithelial neoplasms. Ann. Intern. Med, 111,273-279. [29] Holmes, FA, Walters, RS, Theriault, RL, Forman, AD, Newton, LK,... | |
| Edward Chu - 2004 - 548 стор.
...toxicity modification by liposomal encapsulation. / Clin Oncol 1997;15:987-993. 287. McGuire WP, et al. Taxol: a unique antineoplastic agent with significant...activity in advanced ovarian epithelial neoplasms. Ann Intern Med 1989;1 11:273-279. 288. Kudelka AP, et al. Phase II study of intravenous topotecan as... | |
| Debra S. Prescher-Hughes, Cynthia J. Alkhoudairy - 2007 - 710 стор.
...ovarian cancer. J Clin Oncol. 2000;18(17):3093-3100. 346. McGuire WP, Rowinsky EK, Rosenshein NB, et al. Taxol: a unique antineoplastic agent with significant...activity in advanced ovarian epithelial neoplasms. Ann Intern Med. 1989;! 11:273-279. 347. Kudelka AP, ct al. Phase II study of intravenous topotecan... | |
| Edward Chu, Vincent T. DeVita - 2007 - 572 стор.
...paclitaxel-refractory epithelial ovarian cancer. J Clin Oncol 2ooo;i8(i7):3O93-3ioo. 364. McGuire WP, et al. Taxol: a unique antineoplastic agent with significant...activity in advanced ovarian epithelial neoplasms. Ann Intern Med 1989:111:273-279. 365. Kudelka AP, et al. Phase II study of intravenous topotecan as... | |
| Edward Chu, Vincent T. DeVita - 2007 - 564 стор.
...paclitaxel-refractory epithelial ovarian cancer. J Clin Oncol 2ooo;i8(i7):3O93-3ioo. 322. McGuire WP, et al. Taxol: a unique antineoplastic agent with significant...activity in advanced ovarian epithelial neoplasms. Ann Intern Med 1989:111:273-279. 323. Kudelka AP, et al. Phase II study of intravenous topotecan as... | |
| Michael Clinton Perry - 2008 - 820 стор.
...containing chemotherapy. Resp Med 1994;88:709-710. 87. McGuire WP, Rowinsky EK, Rosenshein NB, et al. Taxol: a unique antineoplastic agent with significant...activity in advanced ovarian epithelial neoplasms. Ann Intern Med 1989;lll:273-279. 88. Arbuck SG, Strauss H, Rowinsky EK, et al. A reassessment of the... | |
| |